| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/15/2006 | US20060127495 Method to treat collagenous connective tissue for implant remodeled by host cells into living tissue |
| 06/15/2006 | US20060127494 Biologically active products |
| 06/15/2006 | US20060127493 Composition for treating psoriasis |
| 06/15/2006 | US20060127492 Sustained improver of muscular fatigue |
| 06/15/2006 | US20060127488 Process of making flowable hemostatic compositions and devices containing such compositions |
| 06/15/2006 | US20060127484 Controlled release composition |
| 06/15/2006 | US20060127469 Entrapping in phosphatidylcholine component; room temperature transdermal delivery system; long shelf life |
| 06/15/2006 | US20060127461 Wound dressings containing an enzyme therapeutic agent |
| 06/15/2006 | US20060127447 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 06/15/2006 | US20060127445 Anti-angiogenic compositions and methods of use |
| 06/15/2006 | US20060127417 administering the toxin directly to a blood vessel, especially following a cardiovascular procedure. |
| 06/15/2006 | US20060127412 Aromatase activator |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127409 Bcr-abl vaccines and methods of use thereof |
| 06/15/2006 | US20060127402 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/15/2006 | US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 06/15/2006 | US20060127397 RAG polypeptides, nucleic acids, and their use |
| 06/15/2006 | US20060127390 Enzymatic inactivation of transmissible spongiform encephalopathy agents and dectection there of |
| 06/15/2006 | US20060127389 Fused protein with the function of both hemolysis and anticoagulation and use of it |
| 06/15/2006 | US20060127388 Variants of glycogen synthase kinase 3 and uses thereof |
| 06/15/2006 | US20060127387 Compositions based on polysaccharides and protein C and methods of using the same for preventing and treating sepsis and other conditions |
| 06/15/2006 | US20060127386 Antioxidant polymer nanocarriers for use in preventing oxidative injury |
| 06/15/2006 | US20060127385 Method for sustaining enos activity |
| 06/15/2006 | US20060127384 Coenzyme Q10 as antiapoptotic agent |
| 06/15/2006 | US20060127380 carrier can be skimmed milk; inventor selected the microbial populations in pickle and salt-preserving clover (Chinese traditional food) as target and applied high cholesterol culture medium |
| 06/15/2006 | US20060127373 Use of substance P for mobilization of Mesenchymal stem cells or proliferation of Mesenchymal stem cells and for wound healing or facilitating wound healing |
| 06/15/2006 | US20060127361 Compositions and methods for inducing gene expression |
| 06/15/2006 | US20060127357 Rapamycin and il-10 for the treatment of immune diseases |
| 06/15/2006 | US20060127356 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 06/15/2006 | US20060127354 Phosphorylated polymers and conjugates thereof |
| 06/15/2006 | US20060127352 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 06/15/2006 | US20060127320 Method of delivering parathyroid hormone to a human |
| 06/15/2006 | US20060127312 Notch signaling in long-term memory formation |
| 06/15/2006 | US20060124125 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 06/15/2006 | CA2630088A1 Signal peptides, nucleic acid molecules and methods of treatment |
| 06/15/2006 | CA2600898A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | CA2595067A1 Methods for improving the structure and function of arterioles |
| 06/15/2006 | CA2592034A1 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 06/15/2006 | CA2590500A1 Use of egf to treat or prevent pathogenic infections and to promote weight gain |
| 06/15/2006 | CA2590180A1 Binding partners of antibodies specific for dendritic cell antigens |
| 06/15/2006 | CA2590177A1 Glyponectin (glycosylated adiponectin) for the treatment of diseases and conditions |
| 06/15/2006 | CA2590061A1 Hsp and supraventricular arrhythmia |
| 06/15/2006 | CA2589935A1 Nucleosides with antiviral and anticancer activity |
| 06/15/2006 | CA2589921A1 Composition for proteasome inhibition |
| 06/14/2006 | EP1669463A1 Casein hydrolyzate, process for producing the same and use thereof |
| 06/14/2006 | EP1669368A1 Use of peptides from the E2 protein of HCV for treating HCV infection |
| 06/14/2006 | EP1669367A1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 06/14/2006 | EP1669086A1 Composition comprising TGF-beta and proteins for treating psoriasis |
| 06/14/2006 | EP1669085A1 Medical agent for prevention and/or treatment of alzheimer disease |
| 06/14/2006 | EP1669084A1 Agent for promoting osteogenesis and/or inhibiting bone resorption |
| 06/14/2006 | EP1669083A1 Heat shock proteins (HSP) and supraventricular arrhythmia |
| 06/14/2006 | EP1668372A1 Elastin peptide fingerprints and analysis methods for mmp12 related to copd |
| 06/14/2006 | EP1668360A2 Multifactorial assay for cancer detection |
| 06/14/2006 | EP1668358A1 Reconstitution medium for protein and peptide formulations |
| 06/14/2006 | EP1668133A1 Coiled-coil fusion proteins comprising cell receptor domains |
| 06/14/2006 | EP1668132A1 Cytokine involved in epithelial-mesenchymal transition |
| 06/14/2006 | EP1668130A2 Modulation of eif4e expression |
| 06/14/2006 | EP1668129A1 Anti-angiogenic peptides from the n-terminus of endostatin |
| 06/14/2006 | EP1668128A1 Treatment of menorrhagia, dysmenorrhoea or endometriosis |
| 06/14/2006 | EP1668031A2 Homogeneous preparations of il-28 and il-29 |
| 06/14/2006 | EP1668030A1 A method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 06/14/2006 | EP1668027A2 Cyclic peptides acting as urotensin-ii antagonists |
| 06/14/2006 | EP1668024A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 06/14/2006 | EP1667998A2 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 06/14/2006 | EP1667724A2 Albumin-binding derivatives of therapeutic peptides |
| 06/14/2006 | EP1667720A1 Combination of a histone deacetylase inhibitor with a death receptor ligand |
| 06/14/2006 | EP1667710A2 Means and methods for the recruitment and identification of stem cells |
| 06/14/2006 | EP1667709A1 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 06/14/2006 | EP1667708A2 Polymer conjugates of interferon- beta with enhanced biological potency |
| 06/14/2006 | EP1667707A1 Methods of stimulating innate immunity using cationic peptides |
| 06/14/2006 | EP1667706A1 G-csf derivative for inducing immunological tolerance |
| 06/14/2006 | EP1667705A1 Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia |
| 06/14/2006 | EP1667704A1 Multiple-arm peptide compounds, methods of manufacture and use in therapy |
| 06/14/2006 | EP1667703A2 A composition and method of treatment for urogenital conditions |
| 06/14/2006 | EP1667702A2 Peptides that inhibit complement activation |
| 06/14/2006 | EP1667701A2 Tumor vaccine |
| 06/14/2006 | EP1667700A2 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 06/14/2006 | EP1667689A1 Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone |
| 06/14/2006 | EP1667671A1 Enhanced method of treatment of growth disorders |
| 06/14/2006 | EP1667648A2 Compositions and methods for treating burns |
| 06/14/2006 | EP1667634A2 Anthrax vaccine |
| 06/14/2006 | EP1667633A2 Polysaccharides for pulmonary delivery of active agents |
| 06/14/2006 | EP1667521A2 Methods for treatment of insulin-like growth factor-1 (igf-1) deficiency |
| 06/14/2006 | EP1496951B1 Wound dressings comprising an oxidoreductase enzyme in hydrated condition |
| 06/14/2006 | EP1471931A4 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 06/14/2006 | EP1438336B1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments |
| 06/14/2006 | EP1404353A4 Methods of using a hyaluronan receptor |
| 06/14/2006 | EP1393075A4 Methods of screening and using inhibitors of angiogenesis |
| 06/14/2006 | EP1381373B1 Medical compositions for use in the treatment or prevention of a functional vitamin b12 deficienfcy |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1372693B1 Peptides for the treatment of wound contracture |
| 06/14/2006 | EP1341819B1 Use of fibrin/fibrinogen peptides and proteins for the manufacture of a medicament |
| 06/14/2006 | EP1309703B1 Kallikrein gene |
| 06/14/2006 | EP1272236B1 Methods and compositions for treating intervertebral disc degeneration |
| 06/14/2006 | EP1272148B1 Compositions for metabolic protection and repair of lips |
| 06/14/2006 | EP1267851B1 Compositions comprising carotenoids and use thereof for preventing hormone induced adverse effects |
| 06/14/2006 | EP1261361B1 Oral, nasal and pulmonary dosage formulations of copolymer 1 (glatiramer acetate) |
| 06/14/2006 | EP1255558B1 Anti-april antibodies and hybridoma cells |
| 06/14/2006 | EP1210100B1 Method of treating traumatic brain using non-steroidal anti-inflammatory drugs |
| 06/14/2006 | EP1119370B1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |